Clinical Trial

Continuous N-of-1 Computational Feasibility Study of a Whole Genome Sequence

Study acronym: B2026N1
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational, computational N-of-1 study that uses previously collected Whole Genome Sequencing (WGS) data from a single adult participant to evaluate the feasibility of a deterministic bioenergetic simulation model. The study does not involve clinical interventions, treatments, or prospective specimen collection. All analyses are performed on existing genomic data in a secure computational environment. The purpose of this study is to determine whether a physics-based metabolic model can successfully integrate individual genomic constraints to generate personalized, hypothesis-driven insights about metabolic pathways. The study focuses on model feasibility and computational performance, not clinical outcomes. No medications, diets, or behavioral interventions are administered or evaluated.
Trial Details
NCT Number NCT07462234
Lead Sponsor Bioactify LLC
Conditions Computational Modeling of Individual Metabolic Pathways
Enrollment 1 participants
Start Date 2026-03-05
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-10